Antibody Response to Single-dose Ebola Vaccine Stable at Two Years Antibody Response to Single-dose Ebola Vaccine Stable at Two Years

Antibody responses to a single dose of a vaccine against the Zaire Ebola virus (ZEBOV) persist for two years after a single-dose injection, according to new findings.Reuters Health Information
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Medscape Today News Source Type: news